title: The guinea pig model for assessing cardiotoxic proclivities of second generation antihistamines.
authors.forename: J A
authors.initials: JA
authors.lastname: Hey
authors.forename: M
authors.initials: M
authors.lastname: del Prado
authors.forename: J
authors.initials: J
authors.lastname: Sherwood
authors.forename: W
authors.initials: W
authors.lastname: Kreutner
authors.forename: R W
authors.initials: RW
authors.lastname: Egan
mesh_terms: D000818:Animals; D000935:Antifungal Agents / Q000633:toxicity; D002090:Butyrophenones / Q000633:toxicity; D002415:Cats; D004195:Disease Models, Animal; D004347:Drug Interactions; D006168:Guinea Pigs; D006634:Histamine H1 Antagonists / Q000633:toxicity*; D006801:Humans; D007654:Ketoconazole / Q000633:toxicity; D010880:Piperidines / Q000633:toxicity; D016593:Terfenadine / Q000633:toxicity; D016171:Torsades de Pointes / Q000139:chemically induced*
chemical_list: D000935:Antifungal Agents; D002090:Butyrophenones; D006634:Histamine H1 Antagonists; D010880:Piperidines; D016593:Terfenadine; D007654:Ketoconazole; C058249:ebastine